COMP <GO>
MTEN vs TMO // OPERATING MARGIN
Mingteng International Corporation Inc. (Class A) (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MTEN 1
— TMO 9
▲ OPERATING MARGIN LEADER: TMO
LAST: $0.84 (-3.37%) • MKT CAP: $6.4M
operating-margins
-3.60%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
operating-margins
17.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MTEN VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MTEN | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 22.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -1.60% | 9.30% | -10.90 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -17.26% | 2.40% | -19.66 | TMO | /fcf-yield <GO> |
| Operating Margin ACTIVE | -3.60% | 17.40% | -21.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | -15.30% | 15.10% | -30.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 15.30% | 3.90% | +11.40 | MTEN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.76 | 4.50 | -3.74 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.4 | 62.9 | -21.50 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.4M | $262.22B | -$262.21B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MTEN REV | TMO REV | MTEN GROSS % | TMO GROSS % | MTEN FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $11.7M | $44.56B | 22.5% | — | -$1.1M | $6.29B |
| FY 2024 | $10.1M | $42.88B | 30.3% | — | -$650.9K | $7.27B |
| FY 2023 | $8.2M | $42.86B | — | — | $1.3M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MTEN // BETA —
TMO // BETA 0.94